RESUMEN
The immune system, which evolved as a protective system, can paradoxically mediate lethal effects when it is over-activated. These effects can be traced back to infected insects and are mainly mediated by phylogenetically old cytokines that have been found already in starfishes and sponges. We hypothesize that these anti-homeostatic effects are important for restricting the cumulative risk of transmission of highly mutating environmental pathogens that may endanger species, particularly when they start to originate and expand. Considering the Darwinian view that evolution is a permanent process, this anti-homeostatic program is preserved and expressed even when there is no risk for the species. Here, we review these aspects and discuss how evolutionary-imposed anti-homeostatic immune programs are expressed during acute and chronic human diseases, which can be further aggravated in the absence of medical interventions. The relevance of early identification of ancestral biomarkers that predict a shift from protective to deleterious immune outcomes is emphasized.
Asunto(s)
Citocinas , Enfermedad Crónica , Homeostasis , HumanosRESUMEN
We have previously shown that long-term potentiation (LTP) induces hippocampal IL-1ß and IL-6 over-expression, and interfering their signalling either inhibits or supports, respectively, LTP maintenance. Consistently, blockade of endogenous IL-1 or IL-6 restricts or favours hippocampal-dependent memory, effects that were confirmed in genetically manipulated mice. Since cytokines are known for their high degree of mutual crosstalk, here we studied whether a network of cytokines with known neuromodulatory actions is activated during LTP and learning. We found that, besides IL-1ß and IL-6, also IL-1 receptor antagonist (IL-1ra) and IL-18, but not TNFα are over-expressed during LTP maintenance in freely moving rats. The increased expression of these cytokines is causally related to an increase in synaptic strength since it was abrogated when LTP was interfered by blockade of NMDA-glutamate receptors. Likewise, IL-1 and IL-6 were found to be over-expressed in defined regions of the hippocampus during learning a hippocampus-dependent task. However, during learning, changes in IL-18 were restricted to the dorsal hippocampus, and no differences in TNFα and IL1-ra expression were noticed in the hippocampus. Noticeably, IL-1ra transcripts were significantly reduced in the prefrontal cortex. The relation between cytokine expression and learning was causal because such changes were not observed in animals from a pseudo-trained group that was subject to the same manipulation but could not learn the task. Taken together with previous studies, we conclude that activation of a cytokine network in the brain is a physiologic relevant phenomenon not only for LTP maintenance but also for certain types of learning.
Asunto(s)
Citocinas/fisiología , Giro Dentado/inmunología , Aprendizaje/fisiología , Potenciación a Largo Plazo/inmunología , Animales , Células Cultivadas , Células HEK293 , Hipocampo/inmunología , Hipocampo/metabolismo , Humanos , Proteína Antagonista del Receptor de Interleucina 1/genética , Proteína Antagonista del Receptor de Interleucina 1/fisiología , Interleucina-18/fisiología , Interleucina-1beta/fisiología , Interleucina-6/fisiología , Ratones , Ratones Mutantes , Receptores Nucleares Huérfanos/antagonistas & inhibidores , Receptores Nucleares Huérfanos/fisiología , Ratas , Ratas Sprague-Dawley , Receptores Citoplasmáticos y Nucleares/fisiología , Factor de Necrosis Tumoral alfa/fisiologíaRESUMEN
The immune system is a homeostatic system that contributes to maintain the constancy of the molecular and cellular components of the organism. Immune cells can detect the intrusion of foreign antigens or alteration of self-components and send information to the central nervous system (CNS) about this kind of perturbations, acting as a receptor sensorial organ. The brain can respond to such signals by emitting neuro/endocrine signals capable of affecting immune reactivity. Thus, the immune system, as other physiologic systems, is under brain control. Under disease conditions, when priorities for survival change, the immune system can, within defined limits, reset brain-integrated neuro-endocrine mechanisms in order to favour immune processes at the expenses of other physiologic systems. In addition, some cytokines initially conceived as immune products, such as IL-1 and IL-6, are also produced in the "healthy" brain by glial cells and even by some neurons. These and other cytokines have the capacity to affect synaptic plasticity acting as mediators of interactions between astrocytes and pre- and post-synaptic neurons that constitute what is actually defined as a tripartite synapse. Since the production of cytokines in the brain is affected by peripheral immune and central neural signals, it is conceivable that tripartite synapses can, in turn, serve as a relay system in immune-CNS communication.
Asunto(s)
Encéfalo/inmunología , Citocinas/inmunología , Sistema Inmunológico/inmunología , Animales , Encéfalo/anatomía & histología , Encéfalo/fisiología , Glucosa/metabolismo , Transportador de Glucosa de Tipo 1/metabolismo , Transportador de Glucosa de Tipo 4/metabolismo , Humanos , Hipotálamo/citología , Hipotálamo/inmunología , Sistema Inmunológico/fisiología , Interleucina-1/inmunología , Interleucina-6/inmunología , Transducción de Señal/fisiologíaRESUMEN
The existence of a network of immunoneuroendocrine interactions that results in the reciprocal modulation of the classical functions of each system is well established at present. Most of the evidence derives from studies on secondary lymphoid organs, such as the spleen and lymph nodes. In this article, several aspects relevant to understand the role of the sympathetic nervous system in the establishment of these interactions in the thymus are discussed. At present, the sympathetic innervation of the thymus, the expression of adrenergic receptors in thymic cells, particularly of ß-adrenergic receptors, and the effect of sympathetic neurotransmitters, although mainly derived from in vitro or pharmacological studies, seem to be relatively well studied. However, other aspects, such as the relevance that immune-sympathetic interactions at the thymic level may have for certain diseases, specially autoimmune or other diseases that primarily involve the activation of the immune system, as well as how the integration of sympathetic and hormonal signals at local levels may affect thymic functions, certainly deserve further investigation.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/patología , Neuroinmunomodulación/fisiología , Sistema Nervioso Simpático/fisiología , Timo/fisiología , Animales , Enfermedades Autoinmunes/fisiopatología , Humanos , Sistema Inmunológico/metabolismo , Neurotransmisores/metabolismo , Receptores Adrenérgicos , Timocitos/metabolismo , Timo/citologíaRESUMEN
Peripheral injection of the endotoxin LPS in rats 3 weeks prior to a second injection of LPS derived from another bacterial strain results in elevated corticosterone and decreased pro-inflammatory cytokines in the blood. We further investigated this model by measuring cytokine expression in the hypothalamus and spleen. In LPS-pretreated rats, hypothalamic expression of a range of cytokines was attenuated in response to the second injection of LPS while splenic expression was elevated. This is the first demonstration that prior exposure to an endotoxin can differentially affect cytokine expression in the brain and peripheral tissues when a host is confronted with a second, acute, pro-inflammatory stimulus. Changes in hypothalamic cytokine expression in endotoxin pretreated rats may provide new evidence for the involvement of central cytokine pathways in modulating peripheral inflammation and mediating psychopathological alterations associated with inflammatory diseases.
Asunto(s)
Citocinas/biosíntesis , Hipotálamo/efectos de los fármacos , Lipopolisacáridos/farmacología , Animales , Citocinas/genética , Expresión Génica , Hipotálamo/metabolismo , Especificidad de Órganos , Ratas , Bazo/efectos de los fármacos , Bazo/metabolismoRESUMEN
We briefly discuss here evidence showing that the capacity of IL-1beta to mediate adjustments of glucose homeostasis can be added to the already well-known pleiotropic effects of this cytokine. Such adjustments, which are necessary for satisfying the high energetic demands of immune/inflammatory responses, can be mediated by effects of endogenous IL-1 exerted at peripheral and brain levels in a concerted action with other cytokines and neuroendocrine mechanisms.
Asunto(s)
Metabolismo Energético/inmunología , Glucosa/metabolismo , Interleucina-1beta/metabolismo , Neuroinmunomodulación/fisiología , Animales , Transportador de Glucosa de Tipo 4/metabolismo , Homeostasis/inmunología , Humanos , Sistema Inmunológico/fisiología , Insulina/metabolismo , Secreción de InsulinaRESUMEN
We studied whether, in parallel to the activity of the hypothalamus-pituitary-adrenal axis and the sympathetic nervous system, hypothalamic cytokine expression and monoaminergic neurotransmitter concentrations are affected during the development and chronification of arthritis induced by immunization of rats with type II collagen. Corticosterone levels were increased only transiently, and were even below the normal range as the disease progressed. Increased adrenaline blood levels and hypothalamic IL-1beta and IL-6 overexpression were observed only during the induction phase of the disease. The increase in hypothalamic noradrenaline content during the symptomatic phase was paralleled by a gradual loss of sympathetic fibers in the joints. Depletion of hypothalamic noradrenergic neurons at this time did not affect the symptomatology. Contrary to observations in healthy animals, no correlation between hypothalamic IL-1beta expression and noradrenaline content was observed in rats with arthritis. The dissociation between hypothalamic cytokine gene expression and noradrenergic neuronal activity, the lack of sustained stimulation of the stress axes, and the loss of sympathetic signals in the joints indicate that the communication between afferent immune messages to the central nervous system and two main efferent anti-inflammatory pathways under control of the brain are disrupted during experimental arthritis.
Asunto(s)
Artritis Experimental/inmunología , Articulaciones/inervación , Neuroinmunomodulación/fisiología , Sistemas Neurosecretores/fisiología , Animales , Artritis Experimental/fisiopatología , Vías Autónomas/inmunología , Vías Autónomas/metabolismo , Catecolaminas/metabolismo , Citocinas/metabolismo , Humanos , Hipotálamo/metabolismo , Articulaciones/inmunología , Articulaciones/fisiopatología , Sistema Nervioso Simpático/fisiopatologíaRESUMEN
Relapsing-remitting multiple sclerosis, the most common form, is characterized by acute neuroinflammatory episodes. In addition to continuous disease-modifying therapy, these relapses require treatment to prevent lesion accumulation and progression of disability. Intravenous methylprednisolone (1-2 g for 3-5 days) is the standard treatment for relapses. However, this treatment is invasive, requires hospitalization, leads to substantial systemic exposure of glucocorticoids, and can only reach modest concentrations in the central nervous system (CNS). Intranasal delivery may represent an alternative to deliver relapse treatment directly to the CNS with higher concentrations and reducing side effects. Histopathological analysis revealed that intranasal administration of methylprednisolone to mice with experimental autoimmune encephalomyelitis (EAE) suppressed the neuroinflammatory peak, and reduced immune cell infiltration and demyelination in the CNS similarly to intravenous administration. Treatment also downregulated Iba1 and GFAP expression. A similar significant reduction of IL-1ß, IL-6, IL-17, IFN-γ, and TNF-α levels in the spinal cord was attained in both intranasal and intravenously treated mice. No damage in the nasal cavity was found after intranasal administration. This study demonstrates that intranasal delivery of methylprednisolone is as efficient as the intravenous route to treat neuroinflammation in EAE.
Asunto(s)
Antiinflamatorios/administración & dosificación , Encefalitis/metabolismo , Encefalomielitis Autoinmune Experimental/metabolismo , Metilprednisolona/administración & dosificación , Médula Espinal/efectos de los fármacos , Administración Intranasal , Animales , Encefalitis/patología , Encefalitis/prevención & control , Encefalomielitis Autoinmune Experimental/patología , Encefalomielitis Autoinmune Experimental/prevención & control , Femenino , Mediadores de Inflamación/metabolismo , Linfocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Ratones Endogámicos C57BL , Microglía/efectos de los fármacos , Médula Espinal/metabolismo , Médula Espinal/patologíaRESUMEN
This study was designed to investigate whether the pattern of hypothalamic and splenic cytokine expression induced by peripheral administration of a bacterial lipopolysaccharide (LPS) is affected by prior exposure to LPS derived from another bacterial strain. Injection of LPS from Salmonella enteritidis (LPS(2)) alone resulted in increased hypothalamic gene expression of IL-1beta, IL-6, TNFalpha, IL-1ra and IL-10. However, pre-exposure to LPS derived from Escherichia coli (LPS(1)) 3 weeks before, significantly attenuated hypothalamic IL-1ra, IL-6 and IL-10 expression. IL-1beta expression also tended to be lower. This pattern contrasted with the robust cytokine expression in the spleen of LPS(2)-treated rats previously exposed to LPS(1), since pre-treatment with endotoxin resulted in a significantly greater response of IL-1beta and IL-1ra to LPS(2). Expression of TNFalpha and IL-10 also tended to be higher. Pre-treatment with LPS(1) did not significantly affect the marked increase in corticosterone and adrenaline blood levels induced by LPS(2). Thus, while endotoxin pre-exposure seemed not to induce a "tolerant" state in the periphery as judged by the immune and endocrine parameters evaluated upon re-stimulation, expression of four of the six cytokines measured was decreased in the hypothalamus. This is the first demonstration that endotoxin priming can differentially affect cytokine expression in the central nervous system and peripheral tissues when a host is confronted with a second, acute, pro-inflammatory stimulus. These results may provide new evidence for the involvement of cytokine pathways in the central nervous system in modulating peripheral inflammation and mediating cognitive and behavioural alterations during inflammatory diseases.
Asunto(s)
Citocinas/biosíntesis , Citocinas/genética , Hipotálamo/metabolismo , Lipopolisacáridos/toxicidad , Bazo/metabolismo , Animales , Catecolaminas/sangre , Corticosterona/sangre , Sondas de ADN , Hipotálamo/efectos de los fármacos , Masculino , ARN/biosíntesis , ARN/genética , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Salmonella enteritidis/química , Bazo/efectos de los fármacosRESUMEN
Dysfunction of the central dopaminergic system is associated with neurodegenerative disorders and mental illnesses such as Parkinson's disease and schizophrenia. Patients suffering from these diseases were reported to exhibit altered immune functions compared to healthy subjects and imbalance of the central dopaminergic system has been suggested as one causative factor for the immune disturbances. However, it is unclear whether the observed immune changes are primary or secondary to the disease. Here we demonstrate that central dopamine (DA) depletion in a rat model of Parkinson's disease induced transient changes in blood leukocyte distribution and cytokine production that were apparent until four weeks after bilateral intrastriatal administration of the neurotoxin 6-hydroxydopamine (6-OHDA). Eight weeks after treatment, no differences in blood immune parameters were anymore evident between neurotoxin-treated and control animals. Nevertheless, animals with a widespread damage of dopaminergic neurons in the nigrostriatal system showed an exacerbated pro-inflammatory response following in vivo challenge with bacterial lipopolysaccharide. Our data indicate that peripheral immune perturbations in the early phase after intrastriatal 6-OHDA administration might have been related to the neurodegenerative process itself whereas the increased sensitivity to the inflammatory stimulus seems to have resulted from an impaired dopaminergic control of prolactin (PRL) and corticosterone (CORT) secretion. The findings demonstrate that the brain dopaminergic system is involved in peripheral immune regulation and suggest that central dopaminergic hypoactivity bears the risk of excessive inflammation, e.g., during infection or tissue injury.
Asunto(s)
Cuerpo Estriado/metabolismo , Citocinas/sangre , Dopamina/metabolismo , Enfermedad de Parkinson/metabolismo , Sustancia Negra/metabolismo , Inhibidores de Captación Adrenérgica/farmacología , Análisis de Varianza , Animales , Recuento de Células , Cuerpo Estriado/efectos de los fármacos , Corticosterona/sangre , Desipramina/farmacología , Modelos Animales de Enfermedad , Citometría de Flujo , Inmunohistoquímica , Leucocitos/metabolismo , Lipopolisacáridos/administración & dosificación , Masculino , Oxidopamina/toxicidad , Prolactina/sangre , Ratas , Ratas Endogámicas F344 , Sustancia Negra/efectos de los fármacos , Factores de Tiempo , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
Evidence indicates that activated immune cells release products, typically cytokines, that can convey information to the brain about the type of ongoing peripheral immune responses. This evidence led colleagues and me to categorize the immune system as another sensorial system that, upon receiving this information, can emit neuroendocrine signals with immunoregulatory functions that can also reset homeostatic mechanisms. Here, I discuss evidence and clues indicating (1) possible mechanisms by which cytokines, such as those of the interleukin 1 (IL-1) family, can reset energy homeostasis to balance the high fuel requirement of the immune system and the brain; and (2) the possibility that the tripartite synapse, which includes astrocytes as a third component, processes and integrates immune signals at brain levels with other sensorial signals that the central nervous system permanently receives.
Asunto(s)
Encéfalo/fisiología , Citocinas/inmunología , Sistema Inmunológico/inmunología , Neuroinmunomodulación/inmunología , Sistemas Neurosecretores/inmunología , Astrocitos/metabolismo , Metabolismo Energético/inmunología , Humanos , Transducción de Señal/inmunologíaRESUMEN
With some exceptions, the sympathetic nervous system has often been regarded as an immunosuppressive system. However, we know now that the immunoregulatory role of the sympathetic nervous system cannot be described in such absolute terms. Indeed, sympathetic neurotransmitters can inhibit or stimulate an immune response depending on numerous variables, which include the type of adrenergic receptor involved, the kind of antigen that triggers the immune response, and the subset of immune cells affected. A most important consideration is that immune and sympathetic responses are phasic phenomena and the step of the immune response at which lymphoid and/or accessory cells are exposed to neurotransmitters, or deprived from their presence, seems decisive for the outcome. The large amount of basic research on the role that the sympathetic nervous system plays in neuroimmunomodulation has prompted studies on its pathological implications. Systemic lupus erythematosus is an autoimmune lymphoproliferative disease that has mainly been associated with a Th2 shift and increased humoral responses. Lpr/lpr mice, which express a defective Fas, are commonly used as a model of this disease, and more recently, also of the autoimmune lymphoproliferative syndrome. We have found that, besides defects in the Fas pathway, lpr/lpr mice have an altered sympathetic innervation, and that this alteration contributes to the pathogenesis of the disease. The results strongly support the hypothesis that the sympathetic nervous system can modulate the expression of autoimmune lymphoproliferative diseases.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades del Sistema Nervioso Autónomo/inmunología , Tejido Linfoide/inmunología , Trastornos Linfoproliferativos/inmunología , Neuroinmunomodulación/inmunología , Sistema Nervioso Simpático/inmunología , Animales , Enfermedades Autoinmunes/fisiopatología , Enfermedades del Sistema Nervioso Autónomo/fisiopatología , Humanos , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/fisiopatología , Tejido Linfoide/fisiopatología , Trastornos Linfoproliferativos/fisiopatología , Ratones , Sistema Nervioso Simpático/fisiopatología , Células Th2/inmunología , Receptor fas/inmunologíaRESUMEN
Several Pavlovian conditioning paradigms have documented the brain's abilities to sense immune-derived signals or immune status, associate them with concurrently relevant extereoceptive stimuli, and reinstate such immune responses on demand. Specifically, the naturalistic relation of food ingestion with its possible immune consequences facilitates taste-immune associations. Here we demonstrate that the saccharin taste can be associated with the immunosuppressive agent cyclosporine A, and that such taste-immune associative learning is subject to reinforcement. Furthermore, once consolidated, this saccharin-immunosuppression engram is resistant to extinction when avoidance behavior is assessed. More importantly, the more this engram is activated, either at association or extinction phases, the more pronounced is the conditioned immunosuppression.
Asunto(s)
Condicionamiento Clásico/fisiología , Extinción Psicológica/fisiología , Terapia de Inmunosupresión , Refuerzo en Psicología , Gusto/fisiología , Análisis de Varianza , Animales , Conducta Animal , Proliferación Celular/efectos de los fármacos , Condicionamiento Clásico/efectos de los fármacos , Corticosterona/sangre , Ciclosporina/sangre , Ciclosporina/farmacología , Extinción Psicológica/efectos de los fármacos , Inmunosupresores/farmacología , Linfocitos/efectos de los fármacos , Linfocitos/fisiología , Masculino , Radioinmunoensayo/métodos , Ratas , Sacarina/administración & dosificación , Edulcorantes/administración & dosificación , Gusto/efectos de los fármacosRESUMEN
The existence of a network of interactions between the immune and nervous systems that influences host defenses and brain functions is now well-established. Here we discuss how immune and classical neuro/sensorial signals are processed in the brain and how neuro-endocrine immunoregulatory and behavioral responses are integrated. Considering the ability of brain cells to produce cytokines, originally described as immune cell products, we propose that the tripartite synapse plays a central role in the integration of neuro-endocrine-immune interactions. We also propose that the immune-neuro-endocrine responses that influence the course of transmissible and other diseases predisposing to infections can be relevant for evolution, either by restoring health or by mediating an active process of negative selection.
Asunto(s)
Evolución Biológica , Sistema Endocrino/fisiología , Sistema Inmunológico/fisiología , Fenómenos Fisiológicos del Sistema Nervioso , Neuroinmunomodulación/fisiología , Sistemas Neurosecretores/fisiología , Animales , Humanos , Fenómenos Fisiológicos del Sistema Nervioso/inmunologíaRESUMEN
The cytokine-mediated stimulation of the hypothalamus-pituitary-adrenal (HPA) axis is relevant for survival during bacterial endotoxemia and certain viral infections. However, only limited information is available regarding the effects of endogenous glucocorticoids on parasite diseases. We have studied this issue using, as a model, C57Bl/6 and Balb/c mice infected with Trypanosoma cruzi, the causal agent of Chagas' disease. These two mouse strains differ in the susceptibility to infection with the parasite. An intense stimulation of the HPA-axis was observed 3 weeks after infection in both strains, but glucocorticoid levels were already increased two- to threefold in the less susceptible Balb/c strain during the first week. Blockade of glucocorticoid receptors with the glucocorticoid antagonist RU486, starting on day 10 after infection, partially reversed the thymic atrophy and decreased the number of CD4(+)CD8(+) thymocytes without affecting parasitemia and the number of inflammatory foci in the heart. However, tumor necrosis factor-alpha blood levels were increased in infected mice of both strains treated with RU486. Furthermore, the blockade of glucocorticoid receptors accelerated death in C57Bl/6J mice and increased lethality to 100% in Balb/c mice. The results obtained represent the first evidence that an endocrine host response that is coupled to the immune process can strongly affect the course of a parasite infection.
Asunto(s)
Glucocorticoides/fisiología , Timo/patología , Trypanosoma cruzi , Tripanosomiasis/inmunología , Adrenalectomía , Animales , Animales Lactantes , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Corticosterona/sangre , Citometría de Flujo , Ratones , Ratones Endogámicos BALB C , Mifepristona/farmacología , Miocardio/patología , Parasitemia , Receptores de Glucocorticoides/antagonistas & inhibidores , Tripanosomiasis/sangre , Tripanosomiasis/patología , Factor de Necrosis Tumoral alfa/análisisRESUMEN
We examined mRNA expression of the pro-inflammatory cytokine IL-1beta in the brainstem, thalamus, and prefrontal cortex in two rat models of neuropathic pain. Rats received a neuropathic injury: spared nerve injury (SNI) or chronic constriction injury (CCI), sham injury, or were minimally handled (control). Neuropathic pain-like behavior was monitored by tracking tactile thresholds. SNI-injured animals showed a robust decrease in tactile thresholds of the injured foot, while CCI-injured animals did not show tactile threshold changes. Ten or 24 days after nerve injury, IL-1beta gene expression in the brain was determined by RT-PCR. IL-1beta expression changes were observed mainly at 10 days after injury in the SNI animals, contralateral to the injury side, with increased expression in the brainstem and prefrontal cortex. The results indicate that neuro-immune activation in neuropathic pain conditions includes supraspinal brain regions, suggesting cytokine modulation of supraspinal circuitry of pain in neuropathic conditions.
Asunto(s)
Tronco Encefálico/metabolismo , Interleucina-1/biosíntesis , Dolor/metabolismo , Enfermedades del Sistema Nervioso Periférico/metabolismo , Animales , Cartilla de ADN , Colorantes Fluorescentes , Lateralidad Funcional/fisiología , Gliceraldehído-3-Fosfato Deshidrogenasas/biosíntesis , Gliceraldehído-3-Fosfato Deshidrogenasas/genética , Masculino , Dolor/etiología , Enfermedades del Sistema Nervioso Periférico/complicaciones , Estimulación Física , ARN/biosíntesis , ARN/genética , Ratas , Ratas Endogámicas WKY , Umbral Sensorial/fisiologíaRESUMEN
The pathogenesis of chronic disabling inflammatory diseases (CDIDs) is poorly understood. Current concepts that focus on abnormalities of the immune system are, in our view, incomplete. Here we propose that chronic disruption of homeostasis through abnormal neuronal and endocrine host responses to transient inflammatory reactions contributes to the appearance of CDIDs. Coordinated reactions of the supersystems (immune, nervous, endocrine, and reproductive) that maintain homeostasis have been evolutionarily conserved to respond to and eliminate foreign agents over a period of days to a few weeks. If the responses of these supersystems fail to return to normal after elimination of the pathogen, a continuous aggressive immune response is created; this situation can trigger development of CDIDs. Maladaptation of the supersystems during CDIDs has not been evolutionarily conserved but is nevertheless still prevalent because a large proportion of these diseases tend to appear after the reproductive phase. We propose that this integrated systems hypothesis may permit better identification of a patient at risk or in the early stages of developing a CDID such as rheumatoid arthritis and enable more coordinated intervention than is presently attempted.
Asunto(s)
Inflamación/etiología , Inflamación/inmunología , Sistemas Neurosecretores/fisiopatología , Adaptación Fisiológica , Evolución Biológica , Enfermedad Crónica , Homeostasis , Humanos , Sistema Inmunológico/inmunología , Tolerancia Inmunológica , Inflamación/diagnóstico , Modelos Inmunológicos , Sistema Nervioso/fisiopatología , ReproducciónRESUMEN
The brain-immune system-joint communication is disrupted during collagen type II (CII) arthritis in DA rats. Since PVG rats are not susceptible to arthritis induction, comparison of hypothalamic and peripheral neuro-endocrine and immune responses between immunized DA and PVG rats might help to explain their different susceptibility to develop the disease. PVG and DA rats were immunized with CII. Corticosterone, neurotransmitters, anti-CII antibodies, and cytokine concentrations in plasma, and hypothalamic neurotransmitters and cytokines were determined by ELISA, Luminex, HPLC and RT-qPCR. Adrenalectomy or sham-operation was performed in PVG and DA rats 14 days before immunization. Basal plasma corticosterone and adrenaline concentrations were significantly higher, and plasma cytokines and hypothalamic noradrenaline were lower in PVG rats than in DA rats. While DA rats developed severe arthritis upon immunization (maximum score 16), only 12 out of 28 PVG rats showed minimal symptoms (score 1-2). The density of sympathetic nerve fibers in arthritic joints of DA rats markedly decreased, but it remained stable in immunized PVG rats. The ratio corticosterone to IL-1ß levels in plasma was markedly higher in immunized PVG rats than in arthritic DA rats. Adrenalectomy resulted in severe arthritis in PVG rats upon immunization with CII. While DA rats show an altered immune-brain communication that favors the development of arthritis, PVG rats express a protective neuro-endocrine milieu, particularly linked to the basal tone of the HPA axis. Mimicking disruption of this axis elicits arthritis in non-susceptible PVG rats.
Asunto(s)
Fibras Adrenérgicas/inmunología , Artritis Experimental/inmunología , Colágeno Tipo II/inmunología , Hipotálamo/metabolismo , Fibras Adrenérgicas/patología , Animales , Artritis Experimental/sangre , Corticosterona/sangre , Epinefrina/sangre , Femenino , Sistema Hipotálamo-Hipofisario/metabolismo , Inmunización , Masculino , Norepinefrina/metabolismo , RatasRESUMEN
Intraperitoneal infection with Taenia crassiceps cysticerci in mice alters several behaviors, including sexual, aggressive, and cognitive function. Cytokines and their receptors are produced in the central nervous system (CNS) by specific neural cell lineages under physiological and pathological conditions, regulating such processes as neurotransmission. This study is aimed to determine the expression patterns of cytokines in various areas of the brain in normal and T. crassiceps-infected mice in both genders and correlate them with the pathology of the CNS and parasite counts. IL-4, IFN-γ, and TNF-α levels in the hippocampus and olfactory bulb increased significantly in infected male mice, but IL-6 was downregulated in these regions in female mice. IL-1ß expression in the hippocampus was unaffected by infection in either gender. Our novel findings demonstrate a clear gender-associated pattern of cytokine expression in specific areas of the brain in mammals that parasitic infection can alter. Thus, we hypothesize that intraperitoneal infection is sensed by the CNS of the host, wherein cytokines are important messengers in the host-parasite neuroimmunoendocrine network.
Asunto(s)
Citocinas/inmunología , Hipocampo , Neurocisticercosis/inmunología , Bulbo Olfatorio , Caracteres Sexuales , Taenia/inmunología , Animales , Femenino , Hipocampo/inmunología , Hipocampo/parasitología , Hipocampo/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Neurocisticercosis/patología , Bulbo Olfatorio/inmunología , Bulbo Olfatorio/parasitología , Bulbo Olfatorio/patologíaRESUMEN
Superantigens, like staphylococcal enterotoxin B (SEB), induce a strong proliferative response followed by clonal deletion of a substantial portion of defined Vbeta T cells. The remaining cells display in vitro anergy. We found that the immune response to SEB was paralleled by biphasic changes in the activity of the sympathetic nervous system. Furthermore, sympathetic denervation resulted in decreased SEB-induced cell proliferation and IL-2 production, and impeded the specific deletion of splenic CD4Vbeta8 cells observed in intact animals without affecting anergy. These studies provide the first evidence of an immunoregulatory cross-talk between sympathetic nerves and superantigen-activated immune cells.